Results 1 to 10 of about 14,471,607 (152)

Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma [PDF]

Journal of International Medical Research, 2020
Objectives Des-gamma-carboxyprothrombin (DCP) is an important serum biomarker for the clinical screening of hepatocellular carcinoma (HCC). This study aimed to evaluate the value of DCP for the early diagnosis of alpha-fetoprotein (AFP)-negative ...
Zhaobo Liu, Min Wu, Dongdong Lin, Ning Li   +3 more
doaj   +6 more sources

Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients [PDF]

Journal of Hepatocellular Carcinoma, 2021
Yang-Xun Pan,1– 3,* Xu-Qi Sun,1,2,* Zi-Li Hu,1,2,* Wa Xie,1,2 Ke-Xin Nie,4 Ai-Ping Fang,5 Ying-Yao Zhang,4 Yi-Zhen Fu,1,2 Jin-Bin Chen,1,2 Jun-Cheng Wang,1,2 Xin Wang,1,2 Yao-Jun Zhang,1,2 Dan-Dan Hu,1,2 Min-Shan Chen1,2 1Collaborative ...
Pan YX, Sun XQ, Hu ZL, Xie W, Nie KX, Fang AP, Zhang YY, Fu YZ, Chen JB, Wang JC, Wang X, Zhang YJ, Hu DD, Chen MS   +13 more
doaj   +6 more sources

Diagnostic value of alpha-fetoprotein, agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma [PDF]

Journal of International Medical Research, 2020
Objective This study aimed to explore the use of different combinations of alpha-fetoprotein (AFP), Lens culinaris agglutinin-reactive AFP (AFP-L3), and des-gamma-carboxyprothrombin (DCP) for the early diagnosis of hepatocellular carcinoma (HCC) in ...
Ting Song, Lili Wang, Bin Su, Weiping Zeng, Taiyi Jiang, Tong Zhang, Guizhen Sun, Hao Wu   +7 more
doaj   +5 more sources

Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case-control study. [PDF]

BMC Gastroenterol, 2015
Hepatocellular Carcinoma (HCC) is a common malignancy occurring globally but with a dismal prognosis. Des-gamma-carboxyprothrombin (DCP) has been reported to be more sensitive and specific than Alpha-fetoprotein (AFP) in the diagnosis of HCC among the White population. Its efficacy among the Black population is yet to be established.
Ette AI, Ndububa DA, Adekanle O, Ekrikpo U.   +3 more
europepmc   +5 more sources

Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy [PDF]

Journal of Hepatocellular Carcinoma, 2023
Meng-Chao Luo,1,2,* Jia-Yi Wu,1,3,* Jun-Yi Wu,1,3 Zhong-Tai Lin,1,2 Yi-Nan Li,3 Zhen-Xin Zeng,3 Shao-Ming Wei,1,2 Mao-Lin Yan1,3 1Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, 350001, People’s Republic of
Luo MC, Wu JY, Wu JY, Lin ZT, Li YN, Zeng ZX, Wei SM, Yan ML   +7 more
doaj   +2 more sources

Effect of abdominal aortic calcification on long‐term outcomes after the first liver resection in very old patients with hepatocellular carcinoma [PDF]

Annals of Gastroenterological Surgery
Aim We previously reported that abdominal aortic calcification is associated with poor overall and recurrence‐free survival after hepatectomy for hepatocellular carcinoma (HCC).
Yosuke Namba, Masahiro Ohira, Yuki Imaoka, Michinori Hamaoka, Masakazu Hashimoto, Takashi Onoe, Daisuke Takei, Koichi Oishi, Megumi Yamaguchi, Tomoyuki Abe, Takeshi Tadokoro, Sotaro Fukuhara, Ko Oshita, Keiso Matsubara, Naruhiko Honmyo, Shintaro Kuroda, Hiroyuki Tahara, Tsuyoshi Kobayashi, Kentaro Ide, Hideki Ohdan   +19 more
doaj   +2 more sources

Economic evaluation of biomarker-based surveillance for Hepatocellular Carcinoma in Thai patients with Compensated Liver Cirrhosis. [PDF]

PLoS ONE
ObjectiveHepatocellular carcinoma (HCC) is the leading cause of cancer-related death in Thailand. However, most Thai patients at high risk of HCC lack access to routine surveillance programs.
Nutcha Pinjaroen, Wirichada Pan-Ngum, Kittiyod Poovorawan, David Wastlund, Fabian Mueller, Peng Lu, Rebecca Sim Shu Yu, Pisit Tangkijvanich   +7 more
doaj   +2 more sources

Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation [PDF]

Journal of Hepatocellular Carcinoma
Wenying Qiao,1– 3,* Jiashuo Li,2,* Qi Wang,2,* Ronghua Jin,2,3 Honghai Zhang1 1Interventional Therapy Center for Oncology, Beijing You’an Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Beijing Di’tan Hospital ...
Qiao W, Li J, Wang Q, Jin R, Zhang H
doaj   +2 more sources

The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis [PDF]

Liver Cancer
Introduction: TP53-induced glycolysis and apoptosis regulator (TIGAR) is a p53 target protein that has critical roles in glycolysis and redox balance. The reports about the effect of TIGAR on prognosis and its biological role in hepatocellular carcinoma (
Katsuya Toshida, Shinji Itoh, Norifumi Iseda, Shugo Tanaka, Kensuke Nakazono, Takahiro Tomiyama, Shohei Yoshiya, Takeo Toshima, Noboru Harada, Kenichi Kohashi, Koji Taniguchi, Yoshinao Oda, Tomoharu Yoshizumi   +12 more
doaj   +2 more sources

ASSESSMENT OF THE VALUE OF MEAN PLATELET VOLUME, DES GAMMA CARBOXY PROTHROMBIN AND ALPHA FETO PROTEIN IN EARLY DETECTION OF HCC [PDF]

Ain Shams Medical Journal, 2022
Background: Hepatocellular carcinoma (HCC) is the commonest primary hepatic neoplasm. The gold standard HCC biomarker is alfa-feto protein (AFP), also mean platelet volume (MPV) is increased in many inflammatory disorders and numerous neoplasms.
Omnia Ellaithy, Nevine Musa, Kadry El Saeed, Shaimaa GadAllah   +3 more
doaj   +1 more source